Front Microbiol by Ayala, Diana I. et al.
fmicb-10-01108 May 16, 2019 Time: 14:41 # 1
ORIGINAL RESEARCH
published: 17 May 2019
doi: 10.3389/fmicb.2019.01108
Edited by:
Jan Kok,
University of Groningen, Netherlands
Reviewed by:
Jasna Novak,
University of Zagreb, Croatia
Robin Anderson,
United States Department
of Agriculture, United States
*Correspondence:
Kendra K. Nightingale
kendra.nightingale@ttu.edu
†Present address:
Guy H. Loneragan,
School of Veterinary Medicine, Texas
Tech University, Lubbock, TX,
United States
Specialty section:
This article was submitted to
Evolutionary and Genomic
Microbiology,
a section of the journal
Frontiers in Microbiology
Received: 22 January 2019
Accepted: 01 May 2019
Published: 17 May 2019
Citation:
Ayala DI, Cook PW, Franco JG,
Bugarel M, Kottapalli KR,
Loneragan GH, Brashears MM and
Nightingale KK (2019) A Systematic
Approach to Identify and Characterize
the Effectiveness and Safety of Novel
Probiotic Strains to Control
Foodborne Pathogens.
Front. Microbiol. 10:1108.
doi: 10.3389/fmicb.2019.01108
A Systematic Approach to Identify
and Characterize the Effectiveness
and Safety of Novel Probiotic Strains
to Control Foodborne Pathogens
Diana I. Ayala1, Peter W. Cook1,2, Jorge G. Franco1, Marie Bugarel1,
Kameswara R. Kottapalli3, Guy H. Loneragan1†, Mindy M. Brashears1 and
Kendra K. Nightingale1*
1 International Center for Food Industry Excellence, Department of Animal and Food Sciences, Texas Tech University,
Lubbock, TX, United States, 2 Influenza Division, National Center for Immunization and Respiratory Diseases, Centers
for Disease Control and Prevention, Atlanta, GA, United States, 3 Center for Biotechnology and Genomics, Texas Tech
University, Lubbock, TX, United States
A total of 44 lactic acid bacteria (LAB) strains originally isolated from cattle feces
and different food sources were screened for their potential probiotic features. The
antimicrobial activity of all isolates was tested by well-diffusion assay and competitive
exclusion on broth against Salmonella Montevideo, Escherichia coli O157:H7 and
Listeria monocytogenes strain N1-002. Thirty-eight LAB strains showed antagonistic
effect against at least one of the pathogens tested in this study. Improved inhibitory
effect was observed against L. monocytogenes with zones of inhibition up to 24 mm
when LAB overnight cultures were used, and up to 21 mm when cell-free filtrates were
used. For E. coli O157:H7 and Salmonella maximum inhibitions of 12 and 11.5 mm
were observed, respectively. On broth, 43 strains reduced L. monocytogenes up to 9.06
log10 CFU/ml, 41 reduced E. coli O157:H7 up to 0.84 log10 CFU/ml, and 32 reduced
Salmonella up to 0.94 log10 CFU/ml 24 h after co-inoculation. Twenty-eight LAB isolates
that exhibited the highest inhibitory effect among pathogens were further analyzed
to determine their antimicrobial resistance profile, adhesion potential, and cytotoxicity
to Caco-2 cells. All LAB strains tested were susceptible to ampicillin, linezolid, and
penicillin. Twenty-six were able to adhere to Caco-2 cells, five were classified as highly
adhesive with > 40 bacterial cells/Caco-2 cells. Low cytotoxicity percentages were
observed for the candidate LAB strains with values ranging from −5 to 8%. Genotypic
identification by whole genome sequencing confirmed all as members of the LAB group;
Enterococcus was the genus most frequently isolated with 21 isolates, followed by
Pediococcus with 4, and Lactobacillus with 3. In this study, a systematic approach was
used for the improved identification of novel LAB strains able to exert antagonistic effect
against important foodborne pathogens. Our findings suggest that the selected panel
of LAB probiotic strains can be used as biocontrol cultures to inhibit and/or reduce the
growth of L. monocytogenes, Salmonella, and E. coli O157:H7 in different matrices, and
environments.
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INTRODUCTION
In the United States (U.S.), an estimated 9.4 million cases of
foodborne illness, 55,961 hospitalizations, and 1,351 deaths per
annum are attributed to 31 identifiable foodborne pathogens
(Scallan et al., 2011). Ninety-five percent of the total illnesses,
hospitalizations, and deaths were estimated to be caused by only
15 pathogens, including Listeria monocytogenes, non-typhoidal
Salmonella and Escherichia coli O157:H7 (Hoffmann et al.,
2015). Non-typhoidal salmonellosis is a leading cause of bacterial
gastroenteritis in the U.S. and worldwide and foodborne illnesses
caused by L. monocytogenes and E. coli O157:H7 are associated
with exceptionally high morbidity and mortality rates (Scallan
et al., 2011). The growing concern of antimicrobial resistance
(AMR) coupled with the increased demand for a safe food supply
by consumers has prompted an increased interest in the use of
probiotics as a natural biocontrol strategy to reduce foodborne
pathogens along the food continuum.
Probiotics are live, naturally occurring microorganisms
that in adequate amounts confer benefits to the host (Fuller,
1992). Probiotics have also emerged as a natural alternative
to antimicrobials in animal feed to promote animal health
[also referred to as direct fed microbials (DFMs) in animal
feed] and chemical interventions to control foodborne
pathogens in human and pet food. Modes of action used
by probiotics include production of antimicrobial compounds
(i.e., bacteriocins and organic acids) and competitive exclusion.
Probiotic strains compete with pathogens for nutrients and
minerals as well as receptors or adhesion sites in the host
intestinal tract, therefore displacing pathogen adhesion to host
intestinal epithelial cells. Probiotics also improve host intestinal
barrier function and activate mucosal immunity (McAllister
et al., 2011). Together these modes of probiotic action and
stimulation of the host immune system, interfere with the
pathogens’ essential cell functions causing leakage of cytoplasmic
components and cytotoxicity, thus leading to pathogen cell
death (Yirga, 2015).
Due to their demonstrated antagonistic effects against
foodborne and spoilage bacteria, the probiotic strains most
commonly used to promote host health and control foodborne
pathogens are lactic acid bacteria (LAB) from the genera of
Lactobacillus and Enterococcus (Imperial and Ibana, 2016). LAB
are an order of gram-positive, non-spore forming cocci, bacilli
or rods that are generally non-respiratory and lack catalase;
they are able to ferment glucose to produce lactic acid or lactic
acid, CO2 and ethanol. Most LAB are beneficial to the host;
however, some LAB are pathogenic or opportunistic pathogens to
animals and humans (e.g., some Streptococcus and Enterococcus
spp.) and careful selection criteria should be evaluated in
selecting probiotic strains to be included as DFMs in animal
feed and probiotics in human and pet food (Yirga, 2015). LAB
are ubiquitous in nature and can be routinely isolated from
vegetation and a wide range of raw foods including milk and
milk products, meat, and produce (Mohania et al., 2008; Quinto
et al., 2014). Additionally, LAB are natural commensals of the
gastrointestinal tract (GIT) of mammals, they constitute the
dominant indigenous lactic microbiota present, this enables LAB
to beneficially affect the host by an improvement of the microbial
profile in the gut (Fuller, 1997; Brashears et al., 2003).
The criteria and safety assessment to select new probiotic
strains to be used as a biocontrol intervention includes
identification and characterization of non-pathogenic strains
with antagonistic features against pathogens in a host or other
systems where pathogen control is needed. Desirable features of
a potential probiotic strain include (i) attach to and colonize
intestinal epithelial cells, (ii) exhibit susceptibility to antibiotics,
(iii) stably survive and have metabolic activity in the small
intestine, and (iv) remain viable during delivery (Krehbiel
et al., 2003; Gaggìa et al., 2010; Sanders et al., 2010; Seo
et al., 2010). Benefits of supplementing animal feed and pet
food with probiotics include, (i) improve resistance to disease
by a beneficial shift in the microbial community, (ii) reduce
pathogen colonization, (iii) stimulate host immunity and (iv)
overall improved host health (Beauchemin et al., 2003; Quigley,
2011). LAB include at least 13 genera where thousands of
genetically diverse strains differ in their ability to benefit the
host through controlling pathogens and improving overall host
health (Liu et al., 2014).
Previous findings have shown that effectiveness to control
enteric pathogens and health benefits conferred by probiotics
depend on strain-specificity, with different results for adhesion,
autoaggregation, and immunomodulatory effect depending on
the strain used (Santosa et al., 2006; Angelakis et al., 2011).
The overall aim of this study was to use a combination
of genotypic and phenotypic assays to characterize a set of
novel LAB strains for their ability to control Salmonella,
E. coli O157:H7 and L. monocytogenes throughout the food
continuum, including pre-harvest applications in animal feed
and post-harvest applications in pet and human food along with
environments associated with pet and human food processing
and handling. A collection of 44 LAB strains from cattle feces
and human food were characterized by agar well-diffusion,
competitive broth exclusion assays (to identify LAB strains with
antagonistic effects against L. monocytogenes, Salmonella, and
E. coli O157:H7), whole genome sequencing (for taxonomic
identification and to predict bacteriocin and virulence gene
carriage), antimicrobial susceptibility, and cell culture assays
(to determine adhesion to and cytotoxicity against intestinal
epithelial cells).
MATERIALS AND METHODS
Bacterial Strains and Growth Conditions
A total of 53 LAB isolates (out of an initial set of > 200 novel
strains) from cattle feces and different food sources including
meat, fruits, and vegetables that showed initial antagonistic
activity against L. monocytogenes, Salmonella, and E. coli
O157:H7 were obtained from the stock culture collection of the
International Center of Food Industry Excellence at Texas Tech
University (ICFIE: TTU). Isolates were streaked for isolation
onto de Man Rogosa and Sharpe (MRS) agar plates (Merck,
Darmstadt, Germany), and incubated aerobically at 37◦C for
48 h to obtain well-isolated colonies. A single colony was
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selected and grown in 9-ml of fresh MRS broth (Criterion,
Hardy Diagnostics, CA, United States) at 37◦C for 12–18 h.
Nine of the 53 LAB strains did not further grow in MRS
broth and were removed from the study. Pure cultures of 44
remaining LAB strains were grown up in MRS broth as described
above, preserved on cryobeads (Key Scientific, Stamford, TX,
United States) and stored at −80◦C until further use. Foodborne
pathogen isolates including L. monocytogenes, Salmonella and
E. coli O157:H7 were streaked onto Tryptic Soy Agar (TSA,
Becton, Dickinson, Le Pont de Chaix, France) and incubated
at 37◦C for 18–24 h. A single colony of each pathogen was
selected and grown individually in 9-ml of Brain Heart Infusion
(BHI) broth (Merck, Darmstadt, Germany). Overnight cultures
of LAB and pathogenic strains were used to perform agar-well
diffusion and competitive exclusion assays as detailed below
to determine the antagonistic activity of all 44 LAB strains
against each pathogen.
Agar-Well Diffusion Assay
This set of experiments was performed based on the method
described previously by Vinderola et al. (2008) with slight
modifications. Overnight cultures (incubated in nutrient rich
media for 12–18 h at 37oC) of foodborne pathogens were
diluted to achieve a concentration of 105 CFU/mL, swabbed
onto BHI plates and incubated at 37oC for 24 h to create a
lawn. To assay the antagonistic activity of each LAB strain
against each foodborne pathogen, five 6-mm wide wells cut
into a BHI agar plate were filled with a 100 µl aliquot of
the following: (i) 108 CFU/mL of each LAB strain overnight
culture in duplicate wells, (ii) cell-free filtrate (CFF) of LAB
overnight cultures, passed through a sterile 0.45µM filter (Sigma-
Aldrich, St. Louis, MO, United States), in duplicate wells, and
(iii) MRS broth (control) in a single well. Plates were first
incubated at 4◦C for 2 h to allow suspensions to diffuse in the
agar followed by incubation for 24 h at 37◦C (Zavisic et al.,
2012). Antagonistic activity was determined by the development
of clear zones of inhibition around each well and measured
using a caliper. Overall scores of inhibition were calculated
by summing up values observed for overnight cultures and
CFF across all three pathogens, and potential LAB probiotic
strains were ranked for antagonistic activity against all three
foodborne pathogens.
Competitive Exclusion Broth Culture
Assay
Overnight cultures of each pathogen and LAB strains were
prepared as described above for agar well diffusion assays and
co-inoculated at 105 and 106 CFU/mL, respectively in Tryptic
Soy Broth (TSB; Oxoid Ltd., Basingstoke, United Kingdom)
supplemented with 1 g l−1 Tween 80 (Acros, Organics, NJ,
United States) and incubated at 37◦C with slight agitation
(130 rpm). A previous study demonstrated that addition of
tween to TSB allows growth of both LAB and gram-negative
pathogens, including E. coli O157:H7 and Salmonella (Cálix-
Lara et al., 2012). Samples were diluted and plated onto
Modified Oxford Agar (MOX; Becton, Dickinson and Company),
Xylose Lysine Tergitol 4 Agar (XLT4; Becton, Dickinson and
Company), MacConkey agar with sorbitol (SMAC; Criterion,
Hardy Diagnostics, CA, United States), and MRS agar plates
to enumerate L. monocytogenes, Salmonella, E. coli O157:H7,
and LAB strains, respectively, at 0, 6, 12, and 24 h of co-
inoculation. MOX, XLT4, and SMAC plates were incubated at
37◦C for 24 h, and MRS plates were incubated at 37◦C for
48 h. Antagonistic activity of each LAB strain was determined by
pathogenic reduction with respect to control samples (pathogen
cultures without LAB) at each time point. As for agar well
diffusion assays, pathogenic reductions were summed up across
all time points and across all three pathogens, and potential LAB
probiotic strains were ranked based on their antagonistic effect.
The top 20 ranking LAB strains from the agar well diffusion and
competitive exclusion broth assays (n = 28 LAB strains in total)
were selected for further phenotypic and genotypic evaluation by
the assays below.
Caco-2 Cell Attachment Assay
The human epithelial intestinal cell line Caco-2 was used to
evaluate the in vitro ability of the top ranking LAB strains
to adhere to the GIT. Caco-2 cells (ATCC HTB-37TM) were
maintained in Eagle’s Minimum Essential Medium (EMEM,
ATCC 30-2003TM) supplemented with 20% fetal bovine serum
(FBS, ATCC 30-2020TM) and 1% of penicillin/streptomycin
solution (10,000 U/mL of penicillin and 10,000 µg/mL
streptomycin) (PenStrep) (Gibco, Thermo Fisher Scientific)
at 37◦C in a water-jacketed incubator with 5% CO2. Three
days before attachment assays were performed, Caco-2 cells
were seeded into 24-well tissue culture plates at a target
density of 5 × 104 cells/well to achieve a confluent density
of 1 × 105 cells/well in EMEM supplemented with 20% FBS
and 1% PenStrep. For each attachment assay, cell culture media
(1 mL/well) was removed and replaced with antibiotic-free
EMEM medium. Duplicate confluent Caco-2 cell monolayers
were then inoculated with an average 1.6× 107 CFU/ ml (CI 95%:
1.1 × 107–2.0 × 107) of each LAB strain to be analyzed resulting
in a multiplicity of infection (MOI) of 52.4, as determined by
plating the LAB inoculum on MRS plates and counting the Caco-
2 cells in a Neubauer chamber. Inoculated Caco-2 cell plates were
returned to the water-jacketed incubator for 30 min to allow for
LAB attachment. Caco-2 cell monolayers were washed once with
1 mL sterile phosphate-buffered saline (PBS, Thermo Scientific,
Rockford, IL, United States) to remove non- or loosely adherent
bacteria. Caco-2 cells were then lysed by addition of 1 mL of
ice-cold water to release adherent LAB bacteria. Appropriate
serial dilutions were plated onto MRS plates, incubated and LAB
were enumerated as detailed above. The attachment efficiency
of each LAB strain was assayed in two biologically independent
experiments each with two technical replicates. Attachment
efficiency was calculated by dividing the average number of
adherent bacterial cells (across biological and technical replicates)
by the number of Caco-2 cells in each well.
Caco-2 Cell Cytotoxicity Assay
The in vitro cytotoxicity of the top ranking LAB strains
against Caco-2 cells was evaluated by using a CytoTox 96
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non-radioactive cytotoxicity kit (Promega, Madison, WI,
United States), which measures release of lactate dehydrogenase
(LDH) upon Caco-2 cell lysis, following manufacturer’s
recommendations. Briefly, Caco-2 cells were seeded on a 24-well
plate and grown to confluence as described above. Caco-2
monolayers were inoculated with each LAB strain at a level
of 1.6 × 107 CFU/ml (CI 95%: 1.1 × 107–2.0 × 107) and
cytotoxicity was evaluated after 24 h by measuring absorbance
(release of LDH) in a microplate reader (Biotek Instruments,
Winooski, VT, United States) at 490 nm. The cytotoxicity of
each LAB strain was evaluated in two biologically independent
experiments each containing two technical replicates. In each
independent experiment, two un-inoculated Caco-2 monolayers
were included and used as maximum lysis controls (according to
the kit instructions) and two un-inoculated Caco-2 monolayers
were included to determine the background absorbance
associated with the medium. Background absorbance was
averaged and subtracted from all individual observed values
for Caco-2 wells inoculated with a LAB strain within each
independent experiment. Percent cytotoxicity was expressed as
the adjusted average absorbance value (subtracting background
absorbance) for each LAB strain divided by the absorbance for
the maximum lysis control.
Antimicrobial Susceptibility Profiling
Antimicrobial susceptibility profiling was performed following
the National Antimicrobial Resistance Monitoring System
(NARMS) protocol (FDA, 2016). LAB strains were streaked onto
TSA plates and incubated at 37◦C for 24 h. A single colony of
each LAB strain was selected and sub-streaked onto TSA plates
containing 5% defibrinated sheep blood (HemoStat Laboratories,
Dixon, CA, United States) and incubated at 37◦C for 24–48 h.
Antibiotic susceptibility was evaluated using the SensititreTM
Gram-positive MIC plate assayed on the SensititreTM automated
antimicrobial susceptibility system (Trek Diagnostic Systems,
Westlake, Ohio) following manufacturer’s instructions.
Enterococcus faecalis ATCC 29212 was used as a quality control
organism. Thirteen antimicrobial agents, included in the MIC
plate assayed, were evaluated in this study including: ampicillin
(AMP), clindamycin (CLI), daptomycin (DAP), erythromycin
(ERY), gentamicin (GEN), levofloxacin (LVX), linezolid
(LZD), penicillin (PEN), rifampicin (RIF), synercid (SYN),
tetracyclin (TET), trimethoprim/sulfamethohazole (SXT), and
vancomycin (VAN). The Minimum Inhibitory Concentration
(MIC) breakpoints for the antimicrobials tested were interpreted
based on the Clinical and Laboratory Standards Institute
(CLSI) (Clinical and Laboratory Standards Institute, 2017).
Whole Genome Sequencing and
Bioinformatics Analyses
A total of 28 novel LAB strains with antagonistic characteristics
toward L. monocytogenes, E. coli O157:H7 and Salmonella
were selected for further genotypic characterization. LAB strains
were cultivated in MRS broth as detailed above, genomic DNA
(gDNA) was isolated and purified using the Invitrogen Purelink
DNA Extraction kit (ThermoFisher Scientific, Waltham, MA,
United States). Pure gDNA was quantified using a Qubit R© 2.0
Fluorometer (Life Technologies, CA, United States), and used
for library preparation with the Nextera XT v2.0 kit (San Diego,
CA, United States) as per manufacturer’s recommendations.
DNA libraries were subjected to paired-end sequenced using
the 2 × 250 basepair (bp) V2 sequencing kit on an Illumina
MiSeq platform (Illumina Inc., United States). Raw reads were
preprocessed and filtered using Trimmomatic version 0.36
(Bolger et al., 2014), which was followed by de novo assembly
using SPAdes version 11 (Bankevich et al., 2012). Resultant
scaffolds were annotated using Prokka v1.13 (Seemann, 2014)
and 31 conserved amino acid coding sequences were identified
through the AMPHORA2 pipeline (Wu and Scott, 2012). The
31 conserved amino acid coding sequences were aligned and
a concatenated alignment was created to compare our novel
LAB strains to a large background of other strains representing
genera in the LAB order. Taxonomic identification for each
of our LAB strains was determined based on the highest
confidence gene set.
Bacteriocins, virulence factors, and potential AMR genes were
identified by comparing genome untranslated gene sequences
identified during genome annotation to the BAGEL3, Virulence
Finder, ResFinder and PlasmidFinder databases, respectively
(Zankari et al., 2012; van Heel et al., 2013; Joensen et al.,
2014). Un-gapped alignments with higher than 95% identity
and 95% query coverage were identified as positive for the
virulence factors and AMR genes were used to confirm the
presence of these genes. A phylogenetic tree was generated using
the concatenated alignment in RAxML (Randomized Axelerated
Maximum Likelihood) (Stamatakis, 2014) on the CIPRES science
gateway (Miller et al., 2010).
Antimicrobial resistance-encoding genes identified by using
the ResFinder v3.0 (Zankari et al., 2012) and PlasmidFinder v2.0
(Carattoli et al., 2014) pipelines from the Center for Genomic
Epidemiology website1 were compared using BLASTn against the
GenBank nucleotide database using default settings for sequence
identification. A multiple genome alignment was created using
Mauve software (v2.4.0) to compare plasmid sequences identified
in strains L22, L24-A, and L25 against plasmid sequence data
from Enterococcus faecium (accession number KJ645709).
Confidence Interval Estimation and
Statistical Analyses
Confidence intervals (95%) for attachment and cytotoxicity assay
data were estimated using the mean and standard deviation
of the ratio of bacterial cells to Caco-2 cells (attachment
efficiency) and percent cytotoxicity (calculated by dividing
adjusted average absorbance values by the maximum lysis
control absorbance value in each experiment), respectively.
Attachment efficiency and percent cytotoxicity values were
analyzed using an ANOVA followed by the Bonferroni familywise
error correction for multiple comparisons. Strain to strain
comparisons were made to identify statistically significant
differences using R coding language (R CoreTeam, 2017). The R
packages: ggplot, phangorn, tidytree, ggtree, phylotools, and ape
1https://cge.cbs.dtu.dk/services/
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(Wickham, 2009; Schliep, 2011; Popescu et al., 2012; Revell,
2012; Yu et al., 2017) were used to describe the relationship
between attachment efficiency, percent cytotoxicity and number
of predicted bacteriocin and virulence genes.
RESULTS
Agar-Well Diffusion Assay
Thirty-eight of the LAB strains showed an antagonistic effect
against at least one of the pathogens tested (Salmonella, E. coli
O157:H7 and L. monocytogenes), the remaining six did not
inhibit or reduce the growth of the pathogens analyzed in this
study. Thirty-seven of the LAB strains showed antimicrobial
activity against L. monocytogenes with clear zones of inhibition
ranging from 8.5 to 24 mm when overnight LAB cultures
were used and from 6.5 to 21 mm when CFF was used.
Twenty strains were antagonistic against E. coli O157:H7 with
a maximum inhibition zone of 12 mm when L15 strain was
used, and 18 were antagonistic against Salmonella, with a
maximum zone of inhibition of 11.5 mm produced by strain
L24-B. No zones of inhibition were observed for either E. coli
O157:H7 or Salmonella when only CFF was used. Overall scores
of inhibition summed across overnight culture and CFF for
all three pathogens ranged from 33.5 to 45 mm for the top
20 LAB strains. Strain L20-B produced the highest ranking
inhibition but was not inhibitory against Salmonella or E. coli
O157:H7. Strain L28 was the highest ranking antagonistic
strain that was effective against all three pathogens. Twelve
of the top 20 LAB strains were originally isolated from
a bovine source (i.e., cattle feces or raw meat), while the
eight remaining isolates were isolated from fruits (n = 6) or
vegetables (n = 2). Overall, increased antimicrobial activity
was found when overnight cultures were used compared to
CFF (Table 1).
Competitive Exclusion in Broth Culture
The antimicrobial activity of all LAB strains evaluated in this
study is shown in Supplementary Table 1. Pathogen reductions
were analyzed at 6, 12, and 24 h after co-inoculation with
respect to un-inoculated control cultures; for E. coli O157:H7
and Salmonella highest reductions were observed 6 h after co-
inoculation (2.03 and 2.53 log10 CFU/ml, respectively). At 12 h,
highest reductions were 1.12 and 1.36 log10 CFU/ml for E. coli
O157:H7 and Salmonella, respectively. Twenty-four hours after
co-inoculation, 43 of the strains reduced L. monocytogenes by
0.12–9.06 log10 CFU/ml. Strains L28 and L20-B had the highest
antimicrobial activity against L. monocytogenes with reductions
of 9.06 and 6.96 log10 CFU/ml, respectively. Forty-one of the
strains reduced E. coli O157:H7 by 0.02 to 0.84 log10 CFU/ml,
where L4-B and L20-B achieved the highest reductions of 0.84
and 0.82 log10 CFU/ml, respectively. Thirty-two of the LAB
strains reduced Salmonella by 0.05–0.94 log10 CFU/ml with
L24-B and L20-B as the most antagonistic with reductions of
0.94 and 0.84 log10 CFU/ml, respectively. Greater antimicrobial
effects were observed against L. monocytogenes compared with
the other pathogens evaluated, notably strain L28 completely
eliminated L. monocytogenes after 24 h after co-inoculation
(Supplementary Table 1).
Pathogen reductions were summed up across time points
and all three pathogens, and novel LAB strains were ranked
based on their increased antimicrobial effect; strain L28 had
the highest reduction across all pathogens tested in this study
(Supplementary Table 1). Overall scores for agar-well diffusion
and competitive exclusion assays were summed up to determine
the top 20 LAB strains (within each assay), L20-B, L28, J7 ranked
as the LAB strains with the greatest antagonistic activity. The
top 20 strains from each assay (n = 28 strains collectively)
were further characterized by cell culture assays, antimicrobial
susceptibility and whole genome sequencing.
Caco-2 Cell Attachment and Cytotoxicity
Assays
The ability of LAB strains to adhere to Caco-2 cells after 30 min
was evaluated in this study. LAB attachment ranged from 4 to
84 bacterial cells/Caco-2 cell (Table 2). According to Candela
et al. (2005) classification of microorganisms based on bacterial
adhesive properties, five including L4-B, L8-A, L3-A, L15, and
L2A were classified as highly adhesive, with > 40 bacterial
cells/Caco-2 cells; 21 of the strains were classified as adhesive
with 5–40 bacterial cells/Caco-2 cells and two were classified as
non-adhesive with < 5 adherent bacterial cells/Caco-2 cells. The
cytotoxic activity of our LAB strain panel was determined based
on the release of the stable cytosolic enzyme LDH in the culture
medium 24 h after bacterial inoculation. Percent cytotoxicity
for the panel ranged from −5 to 8%, with L6B being the least
cytotoxic and J16 the most cytotoxic (Table 2 and Figure 1).
Antimicrobial Susceptibility Profiling
All LAB isolates evaluated were susceptible to AMP, PEN, and
LZD. Resistance to LVX was the most commonly found in
our study (n = 17), followed by CLI (n = 9), VAN and SYN
(each with n = 7), TET and SXT (each with n = 6), and
RIF and GEN (each with n = 1). Intermediate resistance was
mostly commonly observed for ERY, and DAP with 20 and
13 LAB isolates, respectively. Additionally, 7, 4, 3, and 2 LAB
isolates exhibited intermediate resistance to GEN, TET, RIF, and
SYN, respectively (Table 3). Three of the LAB isolates exhibited
resistance to one antimicrobial agent (LVX); 16 were resistant
to two antimicrobials, LVX-DAP was the most common AMR
profile in this study with 9 of the isolates. Additionally, nine of
all the LAB isolates in this study exhibited multidrug-resistance
(MDR) with LVX-VAN-SXT as the most common AMR profile
with 4 isolates, followed by DAP-TET-CLI-SYN with 3MDR
isolates (Table 4).
Whole Genome Sequencing and
Bioinformatics
Genotypic identification by WGS confirmed all as members of
the LAB group; Enterococcus was the genus most frequently
isolated accounting with 21 of the total LAB isolates. The seven
remaining strains were identified as members of the Pediococcus
and Lactobacillus genus with 4 and 3 isolates, respectively.
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TABLE 1 | Antimicrobial activity of novel lactic acid bacteria strains against Listeria monocytogenes, Salmonella, and Escherichia coli O157:H7 sorted by rank of overall
antagonistic activity across all pathogens.
Zone of inhibition averaged from duplicate wells (mm)
Salmonella E. coli O157:H7 L. monocytogenes Overall scoreb
Rank Strain ID Source Culture CFFa Culture CFF Culture CFF Culture and CFF
1 L20-B Bovine 0 0 0 0 24 21 45
2 J7 Grape 0 0 0 0 23 20.5 43.5
3 L24-B Bovine 11.5 0 0 0 17 15 43.5
4 J25 Grape 0 0 0 0 22.5 20.5 43
5 L28 Ground beef 8 0 8 0 14 12.5 42.5
6 J14 Grape 0 0 0 0 23 18 41
7 L15 Bovine 9.5 0 12 0 10 9 40.5
8 J27 Grape 0 0 0 0 21.5 18.5 40
9 J43 Carrot 0 0 0 0 21.5 18.5 40
10 J16 Grape 0 0 0 0 22 17.5 39.5
11 J34 Grape 0 0 0 0 21.5 18 39.5
12 L3-A Bovine 7 0 9 0 11 11 38
13 L14-C Bovine 11 0 7.5 0 10 9 37.5
14 L14-B Bovine 11 0 10.5 0 9 6 36.5
15 L5-B Bovine 6 0 7 0 11.5 11 35.5
16 L2-A Bovine 7 0 8 0 10.5 8.5 34
17 L5-A Bovine 0 0 8 0 15 11 34
18 J19 Cabbage 0 0 0 0 17.5 16 33.5
19 L14-A Bovine 9 0 8.5 0 9.5 6.5 33.5
20 L8-A Bovine 0 0 0 0 20.5 13 33.5
21 L22 Bovine 6 0 7 0 10.5 7 30.5
22 L19 Bovine 6 0 0 0 14 10 30
23 L8-B Bovine 0 0 7 0 10.5 11.5 29
24 L30 Bovine 0 0 0 0 14.5 14 28.5
25 L4-B Bovine 6 0 8 0 14 0 28
26 L4-A Bovine 7 0 6.5 0 11.5 0 25
27 L1 Bovine 7 0 0 0 9 8.5 24.5
28 L23-A Bovine 7 0 6 0 11 0 24
29 L21 Bovine 0 0 7 0 9 7 23
30 L25 Bovine 6.5 0 6.5 0 9 0 22
31 L6-A Bovine 0 0 7 0 10.5 0 17.5
32 L27-A Bovine 0 0 6 0 9 0 15
33 L23-B Bovine 6 0 0 0 8.5 0 14.5
34 L26 Bovine 0 0 6 0 8.5 0 14.5
35 L13-A Bovine 6 0 8 0 0 0 14
36 L29 Bovine 0 0 0 0 10 0 10
37 L11 Bovine 0 0 0 0 9.5 0 9.5
38 L12 Bovine 0 0 0 0 9 0 9
39 L10 Bovine 0 0 0 0 0 0 0
40 L16 Bovine 0 0 0 0 0 0 0
41 L24-A Bovine 0 0 0 0 0 0 0
42 L6-B Bovine 0 0 0 0 0 0 0
43 L7 Bovine 0 0 0 0 0 0 0
44 L9 Bovine 0 0 0 0 0 0 0
a“CFF” indicates cell free filtrate prepared by passing overnight lactic acid bacteria cultures through a 0.45 µM.
bOverall score summed from zones of inhibition observed from overnight lactic acid bacteria culture and CFF across all three pathogens (i.e., Salmonella, E. coli O157:H7
and L. monocytogenes).
E. faecium was the most common species identified in this study
with 11 isolates, followed by E. hirae, and P. acidilactici with 5 and
4 LAB isolates, respectively (Table 5 and Figure 2).
In this study between one and six putative bacteriocins
were identified in 24 of the top LAB strains analyzed
by genome comparison against the BActeriocin GEnome
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TABLE 2 | Novel lactic acid bacteria strains attachment to and cytotoxicity against Caco-2 cells.
Strain ID Av. LAB cells/ Confidence Av. Cytotoxicity Confidence
Caco-2 cella Interval (95%) (%)b Interval (95%)
L4-B 84.25 (67.46–101.04) 5.55 (4.10–7.00)
L8-A 71.37 (68.67–74.06) 2.94 (1.22–4.66)
L3-A 50.63 (28.37–72.89) 1.86 (−0.40–4.11)
L15 45.64 (39.84–51.44) 2.73 (−5.57–11.03)
L2-A 40.43 (19.44–61.42) −1.93 (−2.35–(−1.50))
L14-B 38.25 (31.68–44.81) 6.04 (3.77–8.32)
L25 37.43 (24.23–50.63) 0.59 (−0.89–2.06)
L22 35.31 (22.67–47.96) 5.5 (4.43–6.58)
J14 30.59 (25.28–35.89) 2.04 (0.47–3.61)
L5-B 29.77 (20.36–39.18) 4.98 (0.88–9.08)
L10 27.05 (16.14–37.95) 6.16 (2.17–10.15)
L24-B 26.11 (5.52–46.69) 0.4 (−0.97–1.77)
J7 23.35 (20.11–26.60) 2.62 (−0.19–5.43)
L20-B 23.30 (20.48–26.12) −3.45 (−6.11–(−0.79)
J16 22.80 (20.81–24.80) 8.42 (2.57–14.28)
J19 22.78 (21.57–23.99) −0.54 (−2.02–0.95)
J27 22.09 (20.61–23.56) 0.02 (−5.20–5.24)
J43 21.46 (13.98–28.95) −2.61 (−3.13–(−2.09)
J25 20.73 (17.59–23.87) 0.85 (−0.13–1.83)
J34 20.40 (18.26–22.54) −1.3 (−3.78–1.18)
L5-A 20.31 (16.05–24.57) 0.69 (−0.73–2.12)
L14-A 12.33 (10.47–14.19) 4.84 (2.61–7.08)
L24-A 10.78 (9.79–11.76) −3.63 (−5.57–(−1.68))
L9 10.42 (9.59–11.24) 3.4 (0.19–6.61)
L28 9.91 (8.24–11.57) −3.23 (−5.13–(−1.33))
L6-B 8.67 (5.41–11.93) −4.69 (−7.39–(−1.99))
L30 4.62 (1.88–7.37) −1.69 (−7.08–(−3.69))
L14-C 4.14 (3.30–4.99) 4.35 (2.52–6.17)
aAverage (Av.) lactic acid bacterial cells/Caco-2 cell values were calculated from two biologically independent experiments each with technical replicates.
bAverage (Av.) cytotoxicity values were calculated from two biologically independent experiments each with technical replicates.
mining tool Database. Putative bacteriocins identified
included enterolysin A, enterocin, lactacin F, sactipeptides,
pediocin, closticin, lasso peptide, lanthipeptide, salivaricin,
colicin V, and carnocinCP52. Enterolysin A was the most
common being found in 15 of the isolates, followed
by enterocins, and lactacin F found in 9, and 7 of the
LAB strains, respectively (Table 6). No virulence factors
were identified for 5 of the isolates, and virulence factors
associated with cell adhesion were identified for 13 of the LAB
isolates (Table 5).
Molecular Characterization of
Antimicrobial Resistance Genes
A total of 23 of the investigated strains carried from one to
four acquired genes associated with antimicrobial resistance.
The most common AMR-encoding gene identified among the
LAB strain set was msr(C) gene (n = 11) encoding for an
ABC transporter associated with resistance to erythromycin,
other macrolides, or streptrogramin B antibiotics. The msr(C)
gene was always found alone and was associated with the
phenotypes showing resistant to less antimicrobials (LVX and
LVX DAP profiles). A total of four strains exhibited MDR
phenotypic profiles (DAP TET CLI SYN, and DAP TET
CLI SYN GEN), three of the these strains shared the same
genotype: erm(B), aac(6′)-Iid, ant(6)-Ia and tet(M), encoding for
a rRNA adenine N-6-methyltransferase, an aminoglycoside 6′-N-
acetyltransferase, an aminoglycoside nucleotidyltransferase and a
tetracycline resistance protein, TetM, involved in antibiotic target
modification, respectively. Additionally, six different plasmid
incompatibility types (rep1, rep2, repUS15, rep6, rep9, and
repUS1) were characterized to determine if AMR-encoding genes
were carried on the chromosome or plasmid. Seventeen strains
harbored from one to three plasmids supporting the majority of
AMR-genes were likely carried on plasmids. Further investigation
elucidated that only plasmids belonging to the incompatibility
type repUS1 were carrying antimicrobial genes (Figure 3). LAB
strains, L22, L24-A, and L25, carried such plasmid harboring the
erm(B) and ant(6)-Ia genes, involved in resistance to macrolides
and aminoglycosides, respectively. BLASTn comparison showed
that the repUS1 plasmids had 99% similarity out of 47, 48,
and 68 of the total plasmid sequence registered under the
accession number KJ645709, for the L22, L24-A, and L25 LAB
strains, respectively.
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FIGURE 1 | Attachment, cytotoxicity, virulence gene count, and bacteriocins. Labeled points of strain specific values for cytotoxicity and attachment are mapped to
the x- and y-axis by bacterial cells/caco-2 cell and percent difference, respectively. Gray lines represent the confidence intervals for the mean estimate on either x- or
y-axis. Points are colored and connected via lines of the same color based on each strain genus and species. Each labeled point is also represented by both a
diamond and circle, the size of the diamond represents the number of bacteriocin genes, and the size of the circle represents the number of virulence-associated
genes identified in the sequencing data. Black lines differentiate the adhesive potential as defined by Candela et al. (2005).
TABLE 3 | Summary of antimicrobial susceptibility pattern observed for novel lactic acid bacteria (LAB) strains.
Antimicrobial Antimicrobial Abbreviation Susceptibility No. of non-susceptible
Class agent (%)a isolates classified as
Intermediate Resistant
Penicillin Ampicilin AMP 100.00 (28/28) 0 0
Penicillin PEN 100.00 (28/28) 0 0
Oxazolidinones Linezolid LZD 100.00 (28/28) 0 0
Rifamycin Rifampicin RIF 85.71 (24/28) 3 1
Folate pathway inhibitor Tmp/Sxt SXT 78.57 (22/28) 0 6
Glycopeptide Vancomycin VAN 75.00 (21/28) 0 7
Aminoglycoside Gentamicin GEN 71.43 (20/28) 7 1
Lincosamide Clindamycin CLI 67.86 (19/28) 0 9
Spectrogramin Synercid SYN 67.86 (19/28) 2 7
Tetracycline Tetracycline TET 64.29 (18/28) 4 6
Lipopeptide Daptomycin DAP 53.57 (15/28) 13 0
Fluoroquinolone Levofloxacin LVX 39.29 (11/28) 0 17
Macrolide Erythromycin ERY 28.57 (8/28) 20 0
aMinimum Inhibitory Concentration (MIC) breakpoints were interpreted based on the Clinical and Laboratory Standards Institute (Clinical and Laboratory Standards
Institute, 2017), where isolates were classified into categories of (i) susceptible or (ii) non-susceptible, which includes both resistant and intermediately resistant.
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TABLE 4 | Description of antimicrobial resistance profiles of novel lactic acid bacteria (LAB) strains.
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J16 LVX
1 L5-B LVX
L6-B LVX
L28 TET VAN
L20-B LVX DAP
J7 LVX DAP
J14 LVX DAP
J27 LVX DAP
J43 LVX DAP
2 J34 LVX DAP
J25 LVX DAP
L5-A LVX DAP
J19 LVX DAP
L30 TET CLI
L10 CLI SYN
L14-A CLI SYN
L9 CLI SYN
L3-A VAN SXT
L8-A VAN SXT
L14-C LVX VAN SXT
L15 LVX VAN SXT
3 L14-B LVX VAN SXT
L2-A LVX VAN SXT
L4-B LVX CLI RIF
L24-B DAP TET CLI SYN
>3 L22 DAP TET CLI SYN
L24-A DAP TET CLI SYN
L25 DAP TET CLI SYN GEN
aDAP, daptomicyn; LVX, levofloxacin; TET, tetracycline; VAN, vancomycin; STX, trimethoprim-sulphamethoxazole; CLI, clindamycin; SYN, synercid; RIF, rifampicin;
GEN, gentamicin.
DISCUSSION
Assessment of safety of potential probiotic strains is essential to
be determined prior their use as feed additives. This assessment
should include antimicrobial susceptibility to antibiotics of
human and veterinary importance, attachment and cytotoxicity
to intestinal epithelial cells, determination of presence of
virulence factors and transmissible AMR genes. The aim of
this study was to use a systematic approach to identify safe
and effective novel LAB probiotic strains able to collectively
control three important foodborne pathogens, including
Salmonella, E. coli O157:H7 and L. monocytogenes along the
food continuum through a combined phenotypic and genotypic
characterization strategy.
Antagonistic activity was determined based on
overall reductions or inhibitions across three important
foodborne pathogens (i.e., Salmonella, E. coli O157:H7 and
L. monocytogenes). Results showed that all candidate LAB strains
evaluated were antagonistic to at least one of the pathogens
tested. In agreement with other studies (Das et al., 2016;
Abushelaibi et al., 2017), the antimicrobial effect was shown
to be species and strain-dependent, with E. faecium L20-B as
the top strain across pathogens and in both antagonistic assays;
however, in agar well diffusion the strain was only effective
against L. monocytogenes. Importantly, eight of our candidate
LAB strains had an antagonistic effect against all the pathogens
evaluated in this study. L. salivarius L28 was the top-ranking
LAB strain that was effective against all three pathogens in
both the agar well diffusion and competitive exclusion broth
culture assays. Reductions found in this study were higher than
those observed by other authors (Osuntoki et al., 2008; Angmo
et al., 2016; Abushelaibi et al., 2017). Abushelaibi et al. (2017)
observed zones of inhibition ranging from 0.1 to 2 mm for
Salmonella and E. coli O157:H7 and >2.1 mm of inhibition
for L. monocytogenes compared to the largest reductions of
12 mm for E. coli O157:H7, 11.5 mm for Salmonella, and
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TABLE 5 | Whole genome sequencing of novel lactic acid bacteria (LAB) strains, bioinformatics analysis of sequences to identify putative bacteriocins and
virulence factors.
Strain ID Genus species Putative bacteriocins Virulence genes
L20-B Enterococcus faecium Enterocin B, enterolysin A efaAfm
L28 Lactobacillus salivarius Enterolysin A (2), salivaricin P Non-identified
J7 Enterococcus faecium EnterolysinA, lactacin F efaAfm
J14 Enterococcus faecium Enterocin B, lactacin F, enterocin L50A, enterolysin A efaAfm
J27 Enterococcus faecium Enterolysin A, enterocin B, lactacin F efaAfm
J43 Enterococcus faecium Lactacin F, enterocin (2), enteroloysin A efaAfm
J16 Enterococcus faecium Enterocin B, enterocin L50A, enterolysin A efaAfm
J34 Enterococcus faecium Enterolysin A, lactacin F, enterocin B, enterocin L50 efaAfm
J25 Enterococcus faecium Enterolysin A, enterocin B efaAfm
L5-A Enterococcus faecium Enterocin (2), enterolysin A, lactacin F efaAfm
J19 Enterococcus faecium Colicin V and bacteriocin-production cluster (4) efaAfm
L14-C Enterococcus hirae Enterolysin A (3), closticin, carnocinCP52, sactipeptides Non-identified
L14-A Enterococcus faecalis Lasso peptide camE, hylA, cOB1, efaAfs,
L24-B Lactobacillus mucosae Non-identified Non-identified
L3A Pediococcus acidilactici Pediocin Non-identified
L15 Lactobacillus sakei Non-identified Non-identified
L5-B Enterococcus casseliflavus Non-identified Non-identified
L14-B Pediococcus acidilactici Non-identified Non-identified
L4-B Enterococcus casseliflavus Sactipeptides Non-identified
L22 Enterococcus hirae Enterolysin A (2) Non-identified
L2-A Pediococcus acidilactici Pediocin Non-identified
L8-A Pediococcus acidilactici Pediocin Non-identified
L30 Enterococcus hirae Enterolysin A (2), enterocin, closticin, sactipeptide Non-identified
L25 Enterococcus hirae Lanthipeptide, enterolysin A (2) Non-identified
L10 Enterococcus faecalis Lasso peptide camE, hylA, ebpA, ace, elrA
L24-A Enterococcus hirae Enterolysin A (2), lanthipeptide class II Non-identified
L9 Enterococcus faecalis Lasso peptide camE, hylA, ebpA, ace, elrA
L6-B Enterococcus faecium Lactacin F acm, efaAfm
24 mm for L. monocytogenes observed in this study. Similar
to our results, LAB isolates exhibited greater activity against
L. monocytogenes compared to the other pathogens analyzed
(Abushelaibi et al., 2017). Angmo et al. (2016) characterized
LAB probiotic strains isolated from fermented foods, they also
observed larger antagonistic activity of LAB isolates against
Gram-positive bacteria including L. monocytogenes and weaker
to medium activity against Gram-negative bacteria such as E. coli.
In this study, no zones of inhibition were observed for
Salmonella and E. coli O157:H7 when using LAB CFF.
L. monocytogenes was inhibited by overnight cultures of
candidate LAB probiotic strains and by their CFF. E. faecium L20-
B caused the highest inhibition; E. faecium strains are known by
their anti-listerial activity, this antagonistic action is associated
with the production of bacteriocins, such as enterocins (Corr
et al., 2007; Kasra-Kermanshahi and Mobarak-Qamsari, 2015).
In the competitive exclusion assay, greater inhibition was also
observed for L. monocytogenes. Notably, Lactobacillus salivarius
L28 inhibited L. monocytogenes completely after 24 h of co-
culture. Inhibition was highly probiotic strain dependent, for
Salmonella and E. coli O157:H7 higher antagonistic effects
were observed after 6 h of co-culture. As time increased,
the antagonistic effect decreased, possibly by adaptation of
the pathogens to the decrease in pH and/or the presence of
antimicrobial compounds in the media. For L. monocytogenes the
effect was different: as time increased, improved reductions were
observed. It is important to highlight that all LAB strains tested
remained at high concentrations (109 CFU/ml) in the co-culture
assay throughout the 24 h incubation period.
Enterococcus was the most prevalent genus identified among
our strain collection. Enterococcus strains from bovine and
produce sources ranked among the top ten LAB strains, and
were antagonistic mainly against L. monocytogenes. Enterococcus
strains are ubiquitous in nature and are known by their
bacteriocinogenic effect (Marekova et al., 2003; Sabia et al., 2004).
Bacteriocins are ribosomally synthesized antimicrobial peptides
able to inhibit closely related or non-related bacterial strains
(Yang et al., 2014; Alvarez-Sieiro et al., 2016). Their bactericidal
mechanism is primarily directed toward the receptor-binding
located on bacterial surface, and also by causing cell membrane
permeabilization (Yang et al., 2014). The anti-listerial activity
of our LAB strains could have been associated with the
production of bacteriocins. In fact, 24 of the strains had
between one and six putative bacteriocins. Class II (unmodified
peptides with 30–60 amino acids and a size < 10 kDa),
and class III (heat unstable large proteins with a molecular
weight > 30 kDa) bacteriocins were the most commonly
identified in E. faecium strains with enterocins, and enterolysins
being the most predominant. Bacteriocin-producing bacteria
target cytoplasmic membrane, in Gram-negative bacteria the
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FIGURE 2 | Phylogenetic tree of lactic acid bacteria (LAB) including novel LAB. Sequences of a selection of LAB genera, including sequenced strains, for each
species available to be represented in a phylogenetic tree with mid-point root based on the 31 conserved gene amino acid sequences selected by the AMPHORA2
pipeline. The black bars on the right hand side represent genera markers. The blue diamonds represent collapsed clades of Lactobacillus species that did not
contain strains phylogenetically related to the strains sequenced for this research. Light green highlights represent strains sequenced for this article.
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TABLE 6 | Description and summary of bacteriocins produced by novel lactic acid bacteria (LAB) strains.
LAB Strain ID Genus species Number of bacteriocins in each class
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L20-B Enterococcus faecium – – – – – 1 – – – – 1 2
L28 Lactobacillus salivarius – – 1 – – – – – – – 2 3
J7 Enterococcus faecium – – – – – – 1 – – – 1 2
J14 Enterococcus faecium – – – – – 2 1 – – – 1 4
J27 Enterococcus faecium – – – – – 1 1 – – – 1 3
J43 Enterococcus faecium – – – – – 2 1 – – – 1 4
J16 Enterococcus faecium – – – – – 2 – – – – 1 3
J34 Enterococcus faecium – – – – – 2 – – – – 1 3
J25 Enterococcus faecium – – – – – 1 – – – – 1 2
L5-A Enterococcus faecium – – – – – 2 1 – – – 1 4
J19 Enterococcus faecium – – – – – – – – – 1 – 1
L14-C Enterococcus hirae – – – 1 1 – – – 1 – 3 6
L14-A Enterococcus faecalis 1 – – – – – – – – – – 1
L24-B Lactobacillus mucosae – – – – – – – – – – – 0
L3-A Pediococcus acidilactici – – – – – – – 1 – – – 1
L15 Lactobacillus sakei – – – – – – – – – – – 0
L5-B Enterococcus casseliflavus – – – – – – – – – – – 0
L14-B Pediococcus acidilactici – – – – – – – – – – – 0
L4-B Enterococcus casseliflavus – – – 1 – – – – – – – 1
L22 Enterococcus hirae – – – – – – – – – – 2 2
L2-A Pediococcus acidilactici – – – – – – – 1 – – – 1
L8-A Pediococcus acidilactici – – – – – – – 1 – – – 1
L30 Enterococcus hirae – – – 1 – 1 – – 1 – 2 5
L25 Enterococcus hirae – 1 – – – – – – – – 2 3
L10 Enterococcus faecalis 1 – – – – – – – – – – 1
L24-A Enterococcus hirae – 1 – – – – – – – – 2 3
L9 Enterococcus faecalis – – – – – – 1 – – – – 1
L6-B Enterococcus faecium – – – - – – 1 – – – – 1
presence of a lipopolysaccharide (LPS) layer confers protection
against the bactericidal effects of bacteriocins (Alvarez-Sieiro
et al., 2016). However, Gram-negative bacteria with outer
membranes that have been compromised due to sub-lethal
stresses (i.e., heating, freezing) could be killed by membrane
permeabilization (Bromberg et al., 2004). In Gram-positive
bacteria, the lack of this protective layer make them more
sensitive to these antimicrobial compounds. Salmonella and
E. coli were reduced by our candidate LAB probiotic panel by
0.1–0.9, and 0.02–0.8 log10 CFU/ml, respectively. It has been
suggested that the antagonistic effect of some probiotic strains,
including Lactobacillus, against Salmonella and E. coli O157:H7
is primarily due to the production of organic acids, mainly lactic
and acetic acids (De Keersmaecker et al., 2006; Makras et al.,
2006). Organic acids act by permeabilizing the outer membrane,
allowing antimicrobial compounds to pass through and exert an
antagonistic effect (Alakomi et al., 2000).
The use of probiotics strains is a natural alternative to
reducing the use of antibiotics for growth promotion in animal
agriculture and in human medicine and, possibly, the rapid
emergence of AMR pathogens (Imperial and Ibana, 2016). For
this reason, it is imperative to evaluate the AMR profile of
candidate probiotic strains, where special consideration should
be taken to separate intrinsic (i.e., from point mutations) from
acquired resistance (i.e., from transfer of AMR genes and
plasmids) ( Sanders et al., 2010; Imperial and Ibana, 2016).
A great variability in antimicrobial susceptibility was observed
among the strains tested here. All LAB strains were susceptible
to penicillin (ampicillin and penicillin), and oxazolidinone
(linezolid) antimicrobial classes. These results correlate with the
fact that no genes for resistance against these antimicrobials were
identified here. Our observations are in agreement with those of
Abushelaibi et al. (2017), with most of their probiotic isolates
being susceptible to ampicillin, and penicillin.
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FIGURE 3 | Comparison of antimicrobial resistance (AMR) phenotype and AMR genes identified and description of AMR gene. The most common AMR-encoding
gene identified among the LAB strain set was msr(C) gene encoding for an ABC transporter associated with resistance to erythromycin, other macrolides, or
streptrogramin B antibiotics (MS phenotype). The msr(C) was associated with the phenotypes showing resistant to less antimicrobials (LVX and LVX DAP profiles).
aAMR phenotypes were determined using a Sensititre Gram-Positive MIC plate and using CLSI breakpoints. LVX, levofloxacin; DAP, daptomycin; TET, tetracycline;
VAN, vancomycin; SXT, trimethoprim/sulfamethoxazole; CLI, clindamycin; SYN, synercid; RIF, rifampicin; GEN, gentamycin. Acquired antimicrobial genes were
determined using the ResFinder v.3.1, and the plasmid incompatibility types were determined using PlasmidFinder v.2.0 pipeline. Percentage of similarity of the
genes defining the incompatibility type with the reference sequences of the pipeline database. AMR genes indicated in bold were detected on the same contig that
the incompatibility type genes, therefore most likely located on the plasmid.
It is well known that LAB strains have intrinsic resistance
to vancomycin and beta-lactam (Tejero-Sariñena et al., 2012;
Varankovich et al., 2015). Resistance to levofloxacin was the
most common AMR phenotype observed here. No acquired
genes associated with levofloxacin-resistance were identified.
Levofloxacin is a second-generation fluoroquinolone, where
resistance is related to a point mutation(s) in one or more
genes encoding the type II topoisomerases (gyrA, gyrB, parC,
and parE) present in a chromosomal region known as
the quinolone resistance-determining region (Redgrave et al.,
2014). In Enterococcus species, resistance to levofloxacin has
been associated with the presence of emeA gene (Jia et al.,
2014), which was not identified in the Enterococcus isolates
studied here. Resistance to lincosamides (clindamycin) was
the second most common AMR phenotype, with most of the
resistance isolates belonging to the Enterococcus genus: eight
strains; resistance to lincosamides is conferred by a species-
specific chromosomal gene, lsa(A), which encodes for an ABC
transporter (Singh et al., 2002). Bacteria harboring the lsa(A)
gene express the LSA AMR phenotype with cross-resistance to
lincosamides and spectrogramins (Cattoir and Leclercq, 2017), as
observed in this study.
A high percentage of LAB strains demonstrated intermediate
resistance to erythromycin, which correlated with the presence
of the msr (C) gene, a species-specific chromosomal gene of
E. faecium that encodes for an ABC transporter and efflux pump
(Cattoir and Leclercq, 2017). The msr (C) gene confers also the
MS antimicrobial phenotype (resistance to erythromycin and
type B spectrogramins). Its inactivation has resulted in increased
susceptibility of E. faecium to MSB antimicrobials (Reynolds
and Cove, 2005). Nine of the LAB strains exhibited multi-drug
resistance; to further probe the presence of transferable AMR-
associated genes, analysis of all candidate LAB strain genomes
was performed. Only three of the candidate LAB strains carried
resistance-associated genes in a plasmidic region. The presence of
AMR-associated genes in plasmidic regions or mobile elements is
of concern due to their potential to be horizontally transferred
(Broaders et al., 2013; Imperial and Ibana, 2016). These plasmid-
containing strains were not among the top strains that showed
antagonistic activity against foodborne pathogens and should not
be considered as potential probiotic strains. These results support
the safety of our top twenty selected LAB strains.
To be effective, bacteria in probiotic preparations should
be able to adhere to the intestinal epithelium without causing
cytotoxicity, to ensure longer permanence in the GIT (Pia˛tek
et al., 2012; García-Hernández et al., 2016). The ability of
probiotic strains to adhere to epithelial cells improves their
antagonistic action by allowing them to outcompete pathogens
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for receptors on epithelial cells (Corr et al., 2009). All LAB strains
evaluated were able to attach to Caco-2 cells, with adhesion
efficiencies varying among strains. Adhesion to epithelial cells is
dose, matrix, and strain-dependent (Jensen et al., 2012). Candela
et al. (2005) classified microorganisms based on their adhesive
properties into three categories: (i) non-adhesive strains, when
less than 5 cells adhere to Caco-2, (ii) adhesive strains, when the
effectiveness of adhesion means 5–40 cells adhered to one Caco-2
cell, and (iii) highly adhesive strains, when the level of adhesion
exceeds 40 cells per one epithelial cell (Candela et al., 2005).
Based on this classification, 5 of our isolates were highly adhesive,
21 were adhesive, and 2 were non-adhesive. One important
difference between the Candela et al. (2005) study and the current
study was the amount of time allowed for interaction between
bacterial and Caco-2 cells. We chose 30 min of incubation as
this is sufficient for initial attachment, the 18 h incubation time
used by Candela et al. (2005) could have allowed for subsequent
bacterial growth. Attachment efficiencies of our LAB strains were
higher than those observed by Jankowska et al. (2008); their LAB
isolates, including Lactobacillus and Lactococcus strains, were
able to adhere to Caco-2 cells in a range between 0.5 and 5
bacterial cells per one Caco-2 cell after four h of incubation.
Caco-2 cytotoxicity based on the amount of LDH released into
the medium was low, ranging from −4.69 to 8.42, after 24 h
of inoculation with LAB strains. These values were lower than
those observed by Awaisheh and Ibrahim (2009), who analyzed
two probiotic isolates, L. acidophilus LA102 and L. casei LC232.
Our LAB strains might be used as feed additives without causing
cytotoxicity of epithelial cells, but this is clearly something that
needs further investigation.
Four groups of virulence-associated genes were detected;
two groups in E. faecium and two in E. faecalis. The first
group of E. faecium strains carried a single virulence-associated
gene, efaAfm encoding for EfaA, an important component of
cell adhesion and biofilm formation homologous to PsaA in
S. pneumoniae (Lowe et al., 1995). The second group, carried
two virulence-associated genes, acm and efaAfm. These genes
are both involved in cell adhesion; acm has also been highly
associated with clinical isolates from humans (Nallapareddy
et al., 2008). The third and fourth groups of virulence-
associated genes are contained in three strains of E. faecalis;
these groups comprised seven unique virulence-associated
genes including a hyaluronidase gene, hylA. Hyaluronidases
are normally associated with cell lysis and degradation
(Kayaoglu and Ørstavik, 2004). Of interest, the three hylA-
containing strains L9, L14-A, and L10, did not show higher
levels of cytotoxicity than other LAB strains tested here
(Bonferroni corrected p-value < 0.05). Additional genes
found in these two groups included sex pheromone-associated
genes (camE and cOB1), biofilm and cell wall adhesion genes
(ebpA, efaA, and ace), and genes involved in macrophage
persistence (elrA) (Nakayama et al., 1995; Brinster et al., 2007;
Fisher and Phillips, 2009; Woods et al., 2017).
Overall, the results demonstrate the ability of our selected LAB
probiotic strains to inhibit L. monocytogenes, Salmonella, and
E. coli O157:H7. The strains exhibit important features that could
enhance their antagonistic action (no AMR-encoding genes in
mobile elements, production of bacteriocins, ability to adhere to
epithelial, low cytotoxicity percentages). L. salivarius L28 was the
top-ranking strain that was effective against all three pathogens
in both the agar well diffusion and competitive exclusion broth
assays. L. salivarius L28 not only demonstrated adhesion to
and low cytotoxicity against Caco-2 cells but also carried a
low number of virulence and AMR genes making this strain
a particularly good candidate for further evaluation to control
foodborne pathogens in pre- and post-harvest applications.
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